Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Kateryna Bulatova"'
Autor:
Carlos Guevara, Gonzalo Farias, Kateryna Bulatova, Pablo Alarcón, Wendy Soruco, Carlos Robles, Marcelo Morales
Publikováno v:
Frontiers in Neurology, Vol 8 (2017)
Dissections of extracranial arteries are estimated to account for only 2% of all ischemic strokes but for approximately 20% of strokes in patients younger than 45 years old. Most dissections of extracranial arteries involve some trauma stretch, mecha
Externí odkaz:
https://doaj.org/article/794efe7b0d1944e1876942855803b2ce
Publikováno v:
Frontiers in Aging Neuroscience, Vol 9 (2017)
Objective: The absence of markers for ante-mortem diagnosis of idiopathic Parkinson's disease (IPD), multiple system atrophy (MSA), and progressive supranuclear palsy (PSP) results in these disorders being commonly mistaken for each other, particular
Externí odkaz:
https://doaj.org/article/3e486be4a64947c7a37e0475737f6191
Autor:
Isabel Navarrete, Juan Monsalve, Felipe Aravena, Marcelo Morales, Elena Nieto, Sheila Caba, Hugo Lara, Carlos Guevara O, Kateryna Bulatova
Publikováno v:
Revista médica de Chile. 144:434-441
Background Intravenous thrombolysis with recombinant tissue plasminogen activator (rt-PA) reduces disability in patients with ischemic stroke. However, its implementation in Chilean public general hospitals has been slow and faces some difficulties.
Autor:
Matthew J. Kempton, Kateryna Bulatova, Guido Gonzalez, Carlos Guevara, Nicolas Crossley, Gareth J. Barker
Publikováno v:
Parkinson's Disease, Vol 2016 (2016)
Guevara, C, Bulatova, K, Barker, G J, Gonzalez, G, Crossley, N & Kempton, M J 2016, ' Whole-Brain Atrophy Rate in Idiopathic Parkinson's Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy ', Parkinson's disease, vol. 2016, 9631041 . https://doi.org/10.1155/2016/9631041
Parkinson's Disease
Guevara, C, Bulatova, K, Barker, G J, Gonzalez, G, Crossley, N & Kempton, M J 2016, ' Whole-Brain Atrophy Rate in Idiopathic Parkinson's Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy ', Parkinson's disease, vol. 2016, 9631041 . https://doi.org/10.1155/2016/9631041
Parkinson's Disease
In multiple system atrophy (MSA) and progressive supranuclear palsy (PSP), the absence of surrogate endpoints makes clinical trials long and expensive. We aim to determine annualized whole-brain atrophy rates (a-WBAR) in idiopathic Parkinson’s dise
Autor:
Carlos, Guevara O, Kateryna, Bulatova, Felipe, Aravena, Sheila, Caba, Juan, Monsalve, Hugo, Lara, Elena, Nieto, Isabel, Navarrete, Marcelo, Morales
Publikováno v:
Revista medica de Chile. 144(4)
Intravenous thrombolysis with recombinant tissue plasminogen activator (rt-PA) reduces disability in patients with ischemic stroke. However, its implementation in Chilean public general hospitals has been slow and faces some difficulties.To analyze t